ACMG Celebrates 25 Years of Translating Genetic Discoveries Into Better Patient Care
The College is celebrating its Silver Anniversary in 2016 and we are proud of our 25-year legacy of translating genetic discoveries into better patient care, advocating for our profession and establishing best practices in genetic and genomic medicine.
Our 25th Anniversary is an opportunity to celebrate not only the College’s many important contributions to the practice of genetics in medicine but also to thank you, the ACMG member, for your contributions to the field. Our gratitude goes out to all members and especially to those countless volunteers over the past 25 years who have served on committees, workgroups and special interest groups, the Board, and in many other ways, including as generous donors to the ACMG Foundation for Genetic and Genomic Medicine.
We have a variety of exciting activities planned to both commemorate the progress made in the past 25 years and also to look forward to the next 25 years. Watch for special activities at the Annual Meeting, including an ACMG 25th Anniversary timeline wall and recognition of our Founding Fellows and past presidents.
Please take a moment to read the 25th Anniversary Timeline which shows just a few of the major contributions that the ACMG and ACMG Foundation have made to clinical and laboratory practice over the past 25 years.
ACMG Celebrates 25th Anniversary
NCC Requests Comments on Draft Recommendations for Regional Genetic Service Models
Share your opinion on the future of genetic services, February 1-26, 2016. The National Coordinating Center for Regional Genetic Service Collaboratives (NCC) Regional Support Service Model Workgroup has created a draft recommendation brief, to be provided to the Health Resources Service Administration (HRSA), that identifies current gaps and barriers in genetic services and proposes models to address issues related to access for 2017 and beyond. The draft recommendation brief, as well as instructions on how to submit comments, are available now through February 26th. Please visit the NCC website to let your voice be heard!
ACMG Applauds Investment in Precision/Personalized Medicine
President Obama rolled out a plan on Jan. 30, 2015 to invest $215 million in "precision medicine". ACMG applauds this investment in genomic medicine and we look forward to providing input into the process moving forward as leaders in advancing the field of genetics and genomics into all of healthcare. President Obama said that precision or personalized medicine "gives us one of the greatest opportunities for new medical breakthroughs that we have ever seen." ACMG is already actively developing the standards by which genomic medicine will be practiced including practice guidelines for laboratories and clinicians and is partnered in the Clinical Genomics Resource (ClinGen) Project that is bringing the expertise of those trained in this field to the clinical curation of genomic variation based on data provided by clinical genetics and genomics service providers across the country. Read more about President Obama's Precision Medicine Initiative here.
ACMG thanks its members, Board and staff who work tirelessly on behalf of patients and families every day to make the promise of genomic medicine a reality in improving public health and in preventing and treating genetic diseases.
You can watch the White House video here on the Precision Medicine Initiative - note the actual press conference starts at around the 22:00 minute mark.
There has never been a more exciting time to be involved in genetic medicine and ACMG certainly will continue to play an important role in translating genetic discoveries into better patient care.
ACMG Releases Member Survey Results on Secondary Findings and Reinforces Earlier Recommendations in New Policy Statement on Secondary Findings
The American College of Medical Genetics and Genomics (ACMG) has released two documents "online ahead of print" in its peer-reviewed academic journal, Genetics in Medicine:
1. "American College of Medical Genetics and Genomics (ACMG) Policy Statement: Updated Recommendations Regarding Analysis and Reporting of Secondary Findings in Clinical Genome-Scale Sequencing"
2. "Reporting Genomic Secondary Findings: ACMG Members Weigh In".
Click here to access news release